Deoiled Rice Bran
Related Insights
EIA's Outdated July Forecast: Why Chemical Companies Should Avoid Single-Scenario Planning
The EIA's July outlook was built around assumptions that changed within weeks after the ceasefire collapsed. Chemical procurement and compliance teams should adopt scenario-based planning to strengthen supply chain resilience in an increasingly unpredictable market.
UAN Demand Surges in Europe as Subsidy Rules Shift Buyers Away from NPK
Europe’s fertilizer market is witnessing a sharp rise in UAN fertilizer demand as new subsidy policies redirect growers from traditional NPK blends. This shift is reshaping procurement strategies and regional supply chains, with significant implications for agricultural chemicals. The article explores the drivers, impacts, and future outlook for UAN in the continent.
Helium: Qatar's LNG Halt and the Forgotten Supply Chain
The 2026 Hormuz crisis created one of the most overlooked commodity disruptions in global markets: helium. Damage to Qatar’s Ras Laffan LNG infrastructure reduced helium production capacity, creating a structural supply shortage that may persist for years even as shipping conditions across Hormuz begin improving.
MEG: The 6.5 Million Tonne Gulf Export That Reshaped Asian Polyester Supply Chains
The disruption of Gulf MEG exports has transformed procurement strategies across Asia's polyester industry. As shipments begin moving again, buyers must understand transit timelines, supply recovery patterns and pricing risks before inventories normalize.
The Contradiction Index: Tracking the Gap Between Diplomatic Signals and Physical Reality in Hormuz
July 1 reveals the biggest contradiction of the Hormuz crisis so far: diplomacy suggests progress, but physical shipping data shows continued disruption. For chemical procurement professionals, understanding the gap between political signals and operational reality has become essential for making correct supply chain decisions.
Heparin and Biologics Raw Materials: Supply Chain Review and Procurement Outlook for H2 2026
The biologics supply chain remained resilient through H1 2026 despite higher logistics costs. As heparin production stays concentrated and biologics demand grows, procurement teams should focus on diversification, quality assurance, and long-term supplier partnerships.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.